herbal medicine in cutaneous leishmaniasis

Study of standard treatment of cutaneous leishmaniasis (cryotherapy) in comparison to a traditional herbal remedy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013011512143N1

Enrollment

Registered

2013-02-07

Start date

2013-01-29

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leishmaniasis. Cutaneous leishmaniasis

Interventions

treatment with daily 10 grams of herbal medicine for one month.

treatment with 10-20 Seconds cryotherapy for one month.

Intervention 1: treatment with daily 10 grams of herbal medicine for one month. Intervention 2: treatment with 10-20 Seconds cryotherapy for one month.

Treatment - Drugs

Treatment - Other

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: number of wound less than 3; disease period less than 3 months; without previous treatment; without systemic or other skin disease Exclusion criteria: hypersensitivity to herbal medicine; pregnancy and etc

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Complete treatment of Wound. Timepoint: before treatment, 1,2,3,4 weeks after treatment. Method of measurement: measurement of Wound size.	—

Secondary

Measure	Time frame
Adverse effect. Timepoint: before treatment, 1,2,3,4 weeks after treatment. Method of measurement: question from patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholamreza Hatam

Shiraz University of Medical Sciences

hatamghr@sums.ac.ir+98 71 1235 7282

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026